Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Point prevalence of SARS-CoV-2 infection in Sweden at six time points during 2020.
Groenheit R, Beser J, Kühlmann Berenzon S, Galanis I, van Straten E, Duracz J, Rapp M, Hansson D, Mansjö M, Söderholm S, Muradrasoli S, Risberg A, Ölund R, Wiklund A, Metzkes K, Lundberg M, Bacchus P, Tegmark Wisell K, Bråve A. Groenheit R, et al. Among authors: brave a. BMC Infect Dis. 2022 Nov 17;22(1):861. doi: 10.1186/s12879-022-07858-6. BMC Infect Dis. 2022. PMID: 36396981 Free PMC article.
Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009.
Mörner A, Bråve A, Kling AM, Kühlmann-Berenzon S, Krook K, Hedenskog M, Silhammar I, Ljungman M, Ortqvist A, Andersson S, Brytting M, Thorstensson R, Linde A. Mörner A, et al. Among authors: brave a. PLoS One. 2012;7(12):e53511. doi: 10.1371/journal.pone.0053511. Epub 2012 Dec 28. PLoS One. 2012. PMID: 23285299 Free PMC article.
Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
Glans H, Gredmark-Russ S, Olausson M, Falck-Jones S, Varnaite R, Christ W, Maleki KT, Karlberg ML, Broddesson S, Falck-Jones R, Bell M, Johansson N, Färnert A, Smed-Sörensen A, Klingström J, Bråve A. Glans H, et al. Among authors: brave a. BMC Infect Dis. 2021 May 27;21(1):494. doi: 10.1186/s12879-021-06202-8. BMC Infect Dis. 2021. PMID: 34044758 Free PMC article.
Seroprevalence of SARS-CoV-2 in Sweden, April 26 to May 9, 2021.
Beser J, Galanis I, Enkirch T, Kühlmann Berenzon S, van Straten E, Duracz J, Rapp M, Zakikhany K, Mansjö M, Wigren Byström J, Forsell MNE, Groenheit R, Tegmark Wisell K, Bråve A. Beser J, et al. Among authors: brave a. Sci Rep. 2022 Jun 25;12(1):10816. doi: 10.1038/s41598-022-15183-w. Sci Rep. 2022. PMID: 35752708 Free PMC article.
Rapid emergence of omicron sublineages expressing spike protein R346T.
Groenheit R, Galanis I, Sondén K, Sperk M, Movert E, Bacchus P, Efimova T, Petersson L, Rapp M, Sahlén V, Söderholm S, Valentin Asin K, Zanetti S, Lind Karlberg M, Bråve A, Klingström J, Blom K. Groenheit R, et al. Among authors: brave a. Lancet Reg Health Eur. 2023 Jan;24:100564. doi: 10.1016/j.lanepe.2022.100564. Epub 2022 Dec 10. Lancet Reg Health Eur. 2023. PMID: 36533118 Free PMC article. No abstract available.
Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara.
Sandström E, Nilsson C, Hejdeman B, Bråve A, Bratt G, Robb M, Cox J, Vancott T, Marovich M, Stout R, Aboud S, Bakari M, Pallangyo K, Ljungberg K, Moss B, Earl P, Michael N, Birx D, Mhalu F, Wahren B, Biberfeld G; HIV Immunogenicity Study 01/02 Team. Sandström E, et al. Among authors: brave a. J Infect Dis. 2008 Nov 15;198(10):1482-90. doi: 10.1086/592507. J Infect Dis. 2008. PMID: 18808335 Free PMC article. Clinical Trial.
59 results